Effect of Intradiscal Methylene Blue Injection for the Chronic Discogenic Low Back Pain: One Year Prospective Follow-up Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To evaluate the efficacy of intradiscal methylene blue (MB) injection in patients with chronic discogenic low back pain.Method Twenty patients with discogenic low back pain (4 males, 16 females; mean age 45.6 years) refractory to conservative management were recruited. All subjects underwent MB injection in target lumbar intervertebral discs confirmed by provocative discography. The clinical outcome was assessed by visual analog scale (VAS) and Oswestry disability index (ODI) at baseline and 1, 3, 6 and 12 months after treatment. Successful outcome was described as minimum of 2 points reduction in pain intensity compared with the baseline.Results VAS and ODI significantly decreased after one injection. The average VAS and ODI were reduced significantly from 5.1 and 38.0 at baseline to 3.2 and 27.4 at 3 months after injection (p<0.05). However, the mean score of VAS at 12 month follow-up was 4.5 and we could not observe any difference between 12 months after injection and pretreatment. Eleven of twenty patients (55%) reported successful outcomes after intradiscal MB injection at 3 month follow up and the average VAS was reduced by 3.3±1.1 (p<0.05). At the time of 12 month follow up, pain had relapsed in 6 patients who have had satisfactory effect at 3 month follow up. Successful outcome was maintained in only 5 patients (20%) for 1 year.Conclusion The intradiscal MB injection is a short-term effective minimally invasive treatment indicated for discogenic back pain but it may lose its effectiveness long-term.
Abstract
Objective To evaluate the efficacy of intradiscal methylene blue (MB) injection in patients with chronic discogenic low back pain.Method Twenty patients with discogenic low back pain (4 males, 16 females; mean age 45.6 years) refractory to conservative management were recruited. All subjects underwent MB injection in target lumbar intervertebral discs confirmed by provocative discography. The clinical outcome was assessed by visual analog scale (VAS) and Oswestry disability index (ODI) at baseline and 1, 3, 6 and 12 months after treatment. Successful outcome was described as minimum of 2 points reduction in pain intensity compared with the baseline.Results VAS and ODI significantly decreased after one injection. The average VAS and ODI were reduced significantly from 5.1 and 38.0 at baseline to 3.2 and 27.4 at 3 months after injection (p<0.05). However, the mean score of VAS at 12 month follow-up was 4.5 and we could not observe any difference between 12 months after injection and pretreatment. Eleven of twenty patients (55%) reported successful outcomes after intradiscal MB injection at 3 month follow up and the average VAS was reduced by 3.3±1.1 (p<0.05). At the time of 12 month follow up, pain had relapsed in 6 patients who have had satisfactory effect at 3 month follow up. Successful outcome was maintained in only 5 patients (20%) for 1 year.Conclusion The intradiscal MB injection is a short-term effective minimally invasive treatment indicated for discogenic back pain but it may lose its effectiveness long-term.
참고문헌 (40)
- Andersson GB, "Epidemiologic features of chronic low back pain", Lancet, 354, pp.581~585 (1999)
- Schwarzer AC, "The prevalence and clinical features of internal disc disruption in patients with chronic low back pain", Spine, 20, pp.1878~1883 (1995)
- Andersson GB, "Epidemiology of low back pain", Acta Orthop Scand Suppl, 281, pp.28~31 (1998)
- Peng B, "A randomized placebo-controlled trial of intradiscal methylene blue injection for the treatment of chronic discogenic low back pain", Pain, 149, pp.124~129 (2010)
- Ito M, "Predictive signs of discogenic lumbar pain on magnetic resonance imaging with discography correlation", Spine, 23, pp.1252~1260 (1998)
- Zhou YL, "Diagnosis and minimally invasive treatment of lumbar discogenic pain - a review of the literature", Clin J Pain, 22, pp.468~481 (2006)
- Saal JA, "Natural history and nonoperative treatment of lumbar disc herniation", Spine, 21, pp.2~9 (1996)
- Smith SE, "Outcome of unoperated discogram positive low back pain", Spine, 20, pp.1997~2001 (1995)
- Peng B, "The pathogenesis of discogenic low back pain", J Bone Joint Surg Br, 87, pp.62~67 (2005)
- Moneta GB, "Reported pain during lumbar discography as a function of annular ruptures and disc degeneration. A re-analysis of 833 discograms", Spine, 19, pp.1968~1974 (1994)
- Kallewaard JW, "Discogenic low back pain", Pain Pract, 10, pp.560~579 (2010)
- Pauza KJ, "A randomized, placebo-controlled trial of intradiscal electrothermal therapy for the treatment of discogenic low back pain", Spine J, 4, pp.27~35 (2004)
- Singh K, "Intradiscal therapy: a review of current treatment modalities", Spine, 30, pp.20~26 (2005)
- Rohof O, "Intradiscal pulsed radiofrequency application following provocative discography for the management of degenerative disc disease and concordant pain: a pilot study", Pain Pract, 12, pp.342~349 (2012)
- Freeman BJ, "A randomized, double-blind, controlled trial: intradiscal electrothermal therapy versus placebo for the treatment of chronic discogenic low back pain", Spine, 30, pp.2369~2378 (2005)
- Finch PM, "Radiofrequency heating of painful annular disruptions: one-year outcomes", J Spinal Disord Tech, 18, pp.6~13 (2005)
- McMillan MR, "Percutaneous laser disc decompression for the treatment of discogenic lumbar pain and sciatica: a preliminary report with 3-month follow-up in a general pain clinic population", Photomed Laser Surg, 22, pp.434~438 (2004)
- Skliarenko ET, "Cryotherapy of pain syndromes associated with degenerativedystrophic diseases of the spine", Ortop Travmatol Protez, 10, pp.28~31 (1986)
- Lee SH, "Efficacy of a new navigable percutaneous disc decompression device (L’DISQ) in patients with herniated nucleus pulposus related to radicular pain", Pain Med, 12, pp.370~376 (2011)
- Wainwright M, "Methylene blue - a therapeutic dye for all seasons?", J Chemother, 14, pp.431~443 (2002)
- Cetin M, "Effects of diazeniumdiolates (NONOates) and methylene blue on the reduction of postoperative adhesion in rats", Gynecol Obstet Invest, 57, pp.186~190 (2004)
- Heydrick SJ, "Intraperitoneal administration of methylene blue attenuates oxidative stress, increases peritoneal fibrinolysis, and inhibits intraabdominal adhesion formation", J Surg Res, 143, pp.311~319 (2007)
- Farouk R, "Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani", Br J Surg, 84, pp.670~ (1997)
- Mentes BB, "Intradermal methylene blue injection for the treatment of intractable idiopathic pruritus ani: results of 30 cases", Tech Coloproctol, 8, pp.11~14 (2004)
- Farrokhi MR, "The effect of methylene blue on peridural fibrosis formation after laminectomy in rats: an experimental novel study", Spine J, 11, pp.147~152 (2011)
- "National Toxicology Program. Toxicology and carcinogenesis studies of methylene blue trihydrate (Cas No. 7220-79-3) in F344", N rats and B6C3F1 mice (gavage studies), 2008, pp.540, 1~224
- Salman AE, "Pain on injection of propofol: a comparison ofmethylene blue and lidocaine", J Clin Anesth, 23, pp.270~274 (2011)
- Mayer B, "Inhibition of nitric oxide synthesis by methylene blue", Biochem Pharmacol, 45, pp.367~374 (1993)
- Poveda L, "Peroxynitrite induces gene expression in intervertebral disc cells", Spine, 34, pp.1127~1133 (2009)
- Liu GZ, "Nitric oxide mediates the change of proteoglycan synthesis in the human lumbar intervertebral disc in response to hydrostatic pressure", Spine, 26, pp.134~141 (2001)
- Peng B, "Intradiscal methylene blue injection for the treatment of chronic discogenic low back pain", Eur Spine J, 16, pp.33~38 (2007)
- Kang JD, "Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases", Spine, 22, pp.1065~1073 (1997)
- Farrar JT, "Defining the clinically important difference in pain outcome measures", Pain, 88, pp.287~294 (2000)
- Hägg O, "The clinical importance of changes in outcome scores after treatment for chronic low back pain", Eur Spine J, 12, pp.12~20 (2003)
- Buttermann GR, "The effect of spinal steroid injections for degenerative disc disease", Spine J, 4, pp.495~505 (2004)
- Khot A, "The use of in tradiscal steroid therapy for lumbar spinal discogenic pain: a randomized controlled trial", Spine, 29, pp.833~837 (2004)
- Miller MR, "Treatment of painful advanced internal lumbar disc derangement with intradiscal injection of hypertonic dextrose", Pain Physician, 9, pp.115~121 (2006)
- Poppers PJ, "The effect of methylene blue on neural tissue", Anesthesiology, 33, pp.335~340 (1970)
- Gross SW, "Letter: neurological deficits resulting from intrathecal administration of methylene blue", Neuroradiology, 7, pp.117~ (1974)
- Sharr MM, "Spinal cord necrosis after intrathecal injection of methylene blue", J Neurol Neurosurg Psychiatry, 41, pp.384~386 (1978)
